Bibliography for Obsessive-Compulsive Disorder
This section contains a compilation of recent publications that have shaped the thinking in the field as well as classic works that remain important to the subject reviewed in this issue. This bibliography has been compiled by experts in the field and members of the editorial and advisory boards. Entries are listed chronologically and within years by first author. Articles from the bibliography that are reprinted in this issue are in bold type.
References
1.
American Psychiatric Association: Practice Guideline for the Treatment of Patients with Obsessive-Compulsive Disorder. Am J Psychiatry 2007; 166( Suppl): 1– 96. Available online at http://www.psych.org/psych_pract/treatg/pg/prac_guide.cfm
2.
Saxena S: Is compulsive hoarding a genetically and neurobiologically discrete syndrome? Implications for diagnostic classification. Am J Psychiatry 2007; 164: 380– 384
3.
Abramowitz JS: The psychological treatment of obsessive-compulsive disorder. Can J Psychiatry 2006; 51: 407– 416. Available online at http://ww1.cpa-apc.org:8080/Publications/Archives/CJP/2006/june/cjp-june-06-abramowitz-IR.pdf
4.
Blier P, Habib R, Flament MF: Pharmacotherapies in the management of obsessive-compulsive disorder. Can J Psychiatry 2006; 51: 417– 430. Available online at http://ww1.cpa-apc.org:8080/Publications/Archives/CJP/2006/june/cjp-june-06-blier-IR.pdf
5.
Fineberg NA, Gale TM, Sivakumaran T: A review of antipsychotics in the treatment of obsessive compulsive disorder. J Psychopharmacol 2006; 20: 97– 103
6.
Friedlander L, Desrocher M: Neuroimaging studies of obsessive-compulsive disorder in adults and children. Clin Psychol Rev 2006; 26: 32– 49
7.
Hu XZ. Lipsky RH, Zhu G, Akhtar LA, Taubman J, Greenberg BD, Xu K, Arnold PD, Richter MA, Kennedy JL, Murphy DL, Goldman D: Serotonin transporter promoter gain-of-function genotypes are linked to obsessive-compulsive disorder. Am J Hum Genet 2006; 78: 815– 826
8.
Lovell K, Cox D, Haddock G, Jones C, Raines D, Garvey R, Roberts C, Hadley S: Telephone administered cognitive behaviour therapy for treatment of obsessive compulsive disorder: randomised controlled non-inferiority trial. BMJ 2006; 333: 883
9.
Pittenger C, Krystal JH, Coric V: Glutamate-modulating drugs as novel pharmacotherapeutic agents in the treatment of obsessive-compulsive disorder. NeuroRx 2006; 3: 69– 81
10.
Dell'Osso B, Altamura AC, Allen A, Hollander E: Brain stimulation techniques in the treatment of obsessive-compulsive disorder: current and future directions. CNS Spectr 2005; 10: 966– 979, 983
11.
Fisher PL, Wells A: How effective are cognitive and behavioral treatments for obsessive-compulsive disorder? A clinical significance analysis. Behav Res Ther 2005; 43: 1543– 1558
12.
Foa EB, Liebowitz MR, Kozak MJ, Davies S, Campeas R, Franklin ME, Huppert JD, Kjernisted K, Rowan V, Schmidt AB, Simpson HB, Tu X: Randomized, placebo-controlled trial of exposure and ritual prevention, clomipramine, and their combination in the treatment of obsessive-compulsive disorder. Am J Psychiatry 2005; 162: 151– 161
13.
Mancebo MC, Eisen JL, Grant JE, Rasmussen SA: Obsessive compulsive personality disorder and obsessive compulsive disorder: clinical characteristics, diagnostic difficulties, and treatment. Ann Clin Psychiatry 2005; 17: 197– 204
14.
Mansueto CS, Keuler DJ: Tic or compulsion?: it's Tourettic OCD. Behav Modif 2005; 29: 784– 799
15.
Mataix-Cols D, Rosario-Campos MC, Leckman JF: A multidimensional model of obsessive-compulsive disorder. Am J Psychiatry 2005; 162: 228– 238
16.
Miguel EC, Leckman JF, Rauch S, do Rosario-Campos MC, Hounie AG, Mercadante MT, Chacon P, Pauls DL: Obsessive-compulsive disorder phenotypes: implications for genetic studies. Mol Psychiatry 2005; 10: 258– 275
17.
Tenneij NH, van Megen HJ, Denys DA, Westenberg HG. Behavior therapy augments response of patients with obsessive-compulsive disorder responding to drug treatment. J Clin Psychiatry 2005; 66: 1169– 1175
18.
van Grootheest DS, Cath DC, Beekman AT, Boomsma DI: Twin studies on obsessive-compulsive disorder: a review. Twin Res Hum Genet 2005; 8: 450– 458
19.
van Oppen P, van Balkom AJ, de Haan E, van Dydk R: Cognitive therapy and exposure in vivo alone and in combination with fluvoxamine in obsessive-compulsive disorder: a 5-year follow-up. J Clin Psychiatry 2005; 66: 1415– 1422
20.
Cognitive-behavior therapy, sertraline, and their combination for children and adolescents with obsessive-compulsive disorders: the Pediatric OCD Treatment Study (POTS) randomized controlled trial. JAMA 2004; 292: 1969– 1976
21.
Denys D, Zohar J, Westenberg HG: The role of dopamine in obsessive-compulsive disorder: preclinical and clinical evidence. J Clin Psychiatry 2004; 65( Suppl 14): 11– 17
22.
Kuelz AK, Hohagen F, Voderholzer U. Neuropsychological performance in obsessive-compulsive disorder: a critical review. Biol Psychol 2004; 65: 185– 236
23.
Saxena S, Maidment KM. Treatment of compulsive hoarding. J Clin Psychology 2004; 60(Special Issue: Challenges in Treating OCD): 1143– 1154
24.
Snider LA, Swedo SE. PANDAS: current status and directions for research. Mol Psychiatry 2004; 9: 900– 907
25.
Greist JH, Bandelow B, Hollander E, Marazziti D, Montgomery SA, Nutt DJ, Okasha A, Swinson RP, Zohar J: WCA recommendations for the long-term treatment of obsessive-compulsive disorder in adults. CNS Spectr 2003; 8( 8 Suppl 1): 7– 16
26.
Greist JH, Marks IM, Baer L, Kobak KA, Wenzel KW, Hirsch MJ, Mantle JM, Clary CM: Behavior therapy for obsessive-compulsive disorder guided by a computer or by a clinician compared with relaxation as a control. J Clin Psychiatry 2002; 63: 138– 145
27.
Perugi G, Toni C, Frare F, Travierso MC, Hantouche E, Akiskal HS: Obsessive-compulsive-bipolar comorbidity: a systematic exploration of clinical features and treatment outcome. J Clin Psychiatry 2002; 63: 1129– 1134
28.
Koran LM. Quality of life in obsessive-compulsive disorder. Psychiatric Clin North Am 2000; 23: 509– 518
29.
Summary of the practice parameters for the assessment and treatment of children and adolescents with obsessive-compulsive disorder. J Am Acad Child Adolesc Psychiatry 1998; 37( 10)
30.
Greist JH, Jefferson JW, Kobak KA, Katzelnick DJ, Serlin RC: Efficacy and tolerability of serotonin transport inhibitors in obsessive-compulsive disorder: a meta-analysis. Arch Gen Psychiatry 1995; 52: 53– 60
31.
Baer L, Jenike MA, Black DW, Treece C, Rosenfeld R, Greist J: Effect of axis II diagnoses on treatment outcome with clomipramine in 55 patients with obsessive-compulsive disorder. Arch Gen Psychiatry 1992; 49: 862– 866
32.
Baxter LR Jr, Schwartz JM, Bergman KS, Szuba MP, Guze BH, Mazziotta JC, Alazraki A, Selin CE, Ferng HK, Phelps ME: Caudate glucose metabolic rate changes with both drug and behavior therapy for obsessive-compulsive disorder. Arch Gen Psychiatry 1992; 49: 681– 689
Information & Authors
Information
Published In
History
Published online: 1 July 2007
Published in print: Summer 2007
Authors
Metrics & Citations
Metrics
Citations
Export Citations
If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Simply select your manager software from the list below and click Download.
For more information or tips please see 'Downloading to a citation manager' in the Help menu.
There are no citations for this item
View Options
View options
PDF/ePub
View PDF/ePubGet Access
Login options
Already a subscriber? Access your subscription through your login credentials or your institution for full access to this article.
Personal login Institutional Login Open Athens loginNot a subscriber?
PsychiatryOnline subscription options offer access to the DSM-5-TR® library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.
Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).